The blood-brain barrier (BBB) disruption is a critical step in paraneoplastic neurological syndrome (PNS) development. Several
cytokines have been implicated in BBB breakdown. However, the exact step-by-step mechanism in which PNS develops is unknown, and the relationship between a systemic
neoplasm and BBB is multilevel. The aim of the present study was to examine
serum markers of BBB breakdown (S100B
protein,
neuron-specific enolase, NSE) and concentrations of proinflammatory (
TNF-alpha,
VEGF) and anti-inflammatory/immunosuppressive
cytokines (IL-4), and to establish their interrelationship in patients with PNS. We analyzed 84 patients seropositive for onconeural
antibodies that originated from a cohort of 250 cases with suspected PNS. Onconeural
antibodies were estimated with indirect immunofluorescence and confirmed with Western blotting. Serum S-100B was estimated using electrochemiluminescence immunoassay. NSE,
VEGF,
TNF-alpha and
IL-4 were analyzed with ELISA. We found that
S-100B protein and NSE serum concentrations were elevated in PNS patients without diagnosed
malignancy, and S-100B additionally in patients with peripheral nervous system manifestation of PNS. Serum
VEGF levels showed several abnormalities, including a decrease in anti-Hu positive patients and increase in PNS patients with typical manifestation and/or central nervous system involvement. Increase in
TNF-alpha was observed in patients with undetermined
antibodies. To conclude, the presence of paraneoplastic neurological syndrome in seropositive patients does not affect
serum markers of BBB breakdown, with the exception of the group without clinically demonstrated
malignancy and patients with peripheral manifestation of PNS. S-100B and NSE might increase during early phase of PNS.
VEGF may be involved in typical PNS pathophysiology.